Angiopoietin-1 receptor
Also known as: TEK, TIE2, VMCM, VMCM1
Function
Tyrosine-protein kinase that acts as a cell-surface receptor for ANGPT1, ANGPT2 and ANGPT4 and regulates angiogenesis, endothelial cell survival, proliferation, migration, adhesion and cell spreading, reorganization of the actin cytoskeleton, but also maintenance of vascular quiescence. Has anti-inflammatory effects by preventing the leakage of pro-inflammatory plasma proteins and leukocytes from blood vessels. Required for normal angiogenesis and heart development during embryogenesis. Required for post-natal hematopoiesis. After birth, activates or inhibits angiogenesis, depending on the context. Inhibits angiogenesis and promotes vascular stability in quiescent vessels, where endothelial cells have tight contacts. In quiescent vessels, ANGPT1 oligomers recruit TEK to cell-cell contacts, forming complexes with TEK molecules from adjoining cells, and this leads to preferential activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascades. In migrating endothelial cells that lack cell-cell adhesions, ANGT1 recruits TEK to contacts with the extracellular matrix, leading to the formation of focal adhesion complexes, activation of PTK2/FAK and of the downstream kinases MAPK1/ERK2 and MAPK3/ERK1, and ultimately to the stimulation of sprouting angiogenesis. ANGPT1 signaling triggers receptor dimerization and autophosphorylation at specific tyrosine residues that then serve as binding sites for scaffold proteins and effectors. Signaling is modulated by ANGPT2 that has lower affinity for TEK, can promote TEK autophosphorylation in the absence of ANGPT1, but inhibits ANGPT1-mediated signaling by competing for the same binding site. Signaling is also modulated by formation of heterodimers with TIE1, and by proteolytic processing that gives rise to a soluble TEK extracellular domain. The soluble extracellular domain modulates signaling by functioning as decoy receptor for angiopoietins. TEK phosphorylates DOK2, GRB7, GRB14, PIK3R1; SHC1 and TIE1.
Classification
- Family (Pfam)
- PF00041 fn3, PF10430 Ig_Tie2_1, PF07714 PK_Tyr_Ser-Thr
- InterPro
- EGF, FN3_dom, FN3_sf, Ig-like_dom, Ig-like_dom_sf, Ig-like_fold, Kinase-like_dom_sf, LE_dom, Prot_kinase_dom, Protein_kinase_ATP_BS, RTK, Ser-Thr/Tyr_kinase_cat_dom, Tyr_kin_Tie2_Ig-like_dom-1_N, Tyr_kinase_AS, Tyr_kinase_cat_dom
- Functional cluster
- Immunoglobulin-Domain Cell Adhesion Proteins
Experimental structures · PDB · 16
- 1FVR X-ray 2.20A
- 2GY5 X-ray 2.90A
- 2GY7 X-ray 3.70A
- 2OO8 X-ray 2.20A
- 2OSC X-ray 2.80A
- 2P4I X-ray 2.50A
- 2WQB X-ray 2.95A
- 3BEA X-ray 2.02A
- 3L8P X-ray 2.40A
- 4K0V X-ray 4.51A
- 4X3J X-ray 2.50A
- 5MYA X-ray 2.90A
- … and 4 more
A predicted model is available from AlphaFold.
Gene Ontology · 48
- GO:0016324 apical plasma membrane
- GO:0009925 basal plasma membrane
- GO:0016323 basolateral plasma membrane
- GO:0009986 cell surface
- GO:0005911 cell-cell junction
- GO:0005856 cytoskeleton
- GO:0005576 extracellular region
- GO:0005925 focal adhesion
- GO:0045121 membrane raft
- GO:0005902 microvillus
- GO:0005886 plasma membrane
- GO:0043235 receptor complex
- GO:0005524 ATP binding
- GO:0042802 identical protein binding
- GO:0004672 protein kinase activity
- GO:0038023 signaling receptor activity
- GO:0019199 transmembrane receptor protein kinase activity
- GO:0004714 transmembrane receptor protein tyrosine kinase activity
- GO:0001525 angiogenesis
- GO:0007169 cell surface receptor protein tyrosine kinase signaling pathway
- GO:0007166 cell surface receptor signaling pathway
- GO:0007267 cell-cell signaling
- GO:0071260 cellular response to mechanical stimulus
- GO:0060216 definitive hemopoiesis
- GO:0001935 endothelial cell proliferation
- GO:0072012 glomerulus vasculature development
- GO:0007507 heart development
- GO:0060347 heart trabecula formation
- GO:0016525 negative regulation of angiogenesis
- GO:0043066 negative regulation of apoptotic process
- GO:2000352 negative regulation of endothelial cell apoptotic process
- GO:0050728 negative regulation of inflammatory response
- GO:0045766 positive regulation of angiogenesis
- GO:0010595 positive regulation of endothelial cell migration
- GO:0001938 positive regulation of endothelial cell proliferation
- GO:0070374 positive regulation of ERK1 and ERK2 cascade
- GO:0051894 positive regulation of focal adhesion assembly
- GO:1902533 positive regulation of intracellular signal transduction
- GO:0043410 positive regulation of MAPK cascade
- GO:0051897 positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- GO:0035022 positive regulation of Rac protein signal transduction
- GO:0035025 positive regulation of Rho protein signal transduction
- GO:2000351 regulation of endothelial cell apoptotic process
- GO:0032878 regulation of establishment or maintenance of cell polarity
- GO:0043114 regulation of vascular permeability
- GO:0002040 sprouting angiogenesis
- GO:0034446 substrate adhesion-dependent cell spreading
- GO:0048014 Tie signaling pathway
Disease associations
- multiple cutaneous and mucosal venous malformations MONDO:0010842
- glaucoma 3, primary congenital, E MONDO:0014998
Drugs targeting this protein · 8
- FORETINIB inhibitor
- REGORAFENIB inhibitor
- CEP-11981 inhibitor
- VANDETANIB inhibitor
- ALTIRATINIB inhibitor
- CE-245677 inhibitor
- GLESATINIB inhibitor
- PEXMETINIB inhibitor
Related proteins · sequence + function similarity
- Angiopoietin-1 receptor 0.99
- Angiopoietin-1 receptor 0.99
- Macrophage colony-stimulating factor 1 receptor 0.83
- Ephrin type-A receptor 3 0.82
- Ephrin type-A receptor 3 0.82
- Ephrin type-A receptor 3 0.82
- Ephrin type-A receptor 7 0.82
- Ephrin type-A receptor 7 0.82
- Vascular endothelial growth factor receptor 3 0.81
- Ephrin type-A receptor 7 0.81
- Ephrin type-A receptor 7 0.81
- Vascular endothelial growth factor receptor 2 0.81
Co-cited proteins · studied together in the literature
- Angiopoietin-1 7 shared papers
- Angiopoietin-2 7 shared papers
- Tyrosine-protein kinase receptor Tie-1 1 shared papers
- Angiopoietin-1 receptor 3 shared papers
- Angiopoietin-2 2 shared papers
- TNFAIP3-interacting protein 2 1 shared papers
- Receptor-type tyrosine-protein phosphatase beta 2 shared papers
- Angiopoietin-4 2 shared papers
- Vascular endothelial growth factor receptor 2 1 shared papers
- SHC-transforming protein 1 1 shared papers
- E3 ubiquitin-protein ligase CBL 1 shared papers
- Angiopoietin-4 1 shared papers
Literature · 38 cited papers
- Characterization of ANGPT2 mutations associated with primary lymphedema. Sci. Transl. Med. · 2020
- Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity. J. Clin. Invest. · 2016
- Targeting the ANGPT-TIE2 pathway in malignancy. Nat. Rev. Cancer · 2010
- Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol. Histopathol. · 2010
- Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur. J. Hum. Genet. · 2010
- Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo. Bioorg. Med. Chem. Lett. · 2009
- Angiopoietin-1-induced ubiquitylation of Tie2 by c-Cbl is required for internalization and degradation. Biochem. J. · 2009
- VE-PTP controls blood vessel development by balancing Tie-2 activity. J. Cell Biol. · 2009
- Tie2 is tied at the cell-cell contacts and to extracellular matrix by angiopoietin-1. Exp. Mol. Med. · 2009
- Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. · 2009
- Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol. Cell. Biol. · 2009
- Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. · 2009
- … and 26 more in the literature graph